6ix — Find Your Next Investment

Discover investor relations events, company profiles, and opportunities on 6ix. Connect with public companies and attend live investor events.

Please enable JavaScript to use all features of 6ix.com.

Oorspronkelijke tekst

Deze vertaling beoordelen

Je feedback wordt gebruikt om Google Translate te verbeteren

Latest Press Releases

Time	Headline
Just now	SFG Quarterly Activities/Appendix 4CCash Flow Report
Just now	BSA Announces On-Market Share Buy-Back
Just now	Placement
Just now	Q3 FY26 Activities Report and Appendix 4C
Just now	FY26 Q1 Quarterly Activities Report and Appendix 4C

About

Ose Immunotherapeutics Sa — investor relations, events, news, and company updates on 6ix.

Latest News

OSE Immunotherapeutics Announces Presentation of TEDOVA Phase 2 Topline Results of Tedopi® in Ovarian Cancer at the ASCO 2026 Meeting

OSE Immunotherapeutics to Present a Novel, First-in-Class, FPR2 Agonist Monoclonal Antibody in the Resolution of Chronic Inflammation at the AAI 2026 Meeting

OSE Immunotherapeutics Evolves its Leadership Team

OSE Immunotherapeutics to Present at Upcoming Investor Conferences

OSE Immunotherapeutics Announces its 2026 Financial Calendar

Community Chat

Ask AI